US Stock MarketDetailed Quotes

CMMB Chemomab Therapeutics

Watchlist
  • 0.640
  • -0.019-2.90%
Close Apr 26 16:00 ET
9.09MMarket Cap0.31P/E (TTM)

Chemomab Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-10.77%25.46M
31.04%8.2M
70.09%9.05M
130.72%28.53M
72.01%8.64M
187.69%8.32M
127.17%6.25M
213.13%5.32M
107.08%12.37M
158.70%5.02M
Selling and administrative expenses
-38.75%7.08M
-4.94%3.18M
-16.04%2.16M
91.55%11.56M
4.01%2.75M
106.13%2.89M
130.98%3.34M
375.09%2.58M
368.40%6.03M
283.87%2.64M
-General and administrative expense
-38.75%7.08M
-4.94%3.18M
-16.04%2.16M
91.55%11.56M
4.01%2.75M
106.13%2.89M
130.98%3.34M
375.09%2.58M
368.40%6.03M
283.87%2.64M
Research and development costs
8.27%18.38M
72.27%5.02M
150.89%6.89M
168.03%16.98M
147.38%5.9M
264.69%5.42M
122.95%2.91M
137.25%2.75M
35.23%6.33M
90.03%2.38M
Operating profit
10.77%-25.46M
-31.04%-8.2M
-70.09%-9.05M
-130.72%-28.53M
-72.01%-8.64M
-187.69%-8.32M
-127.17%-6.25M
-213.13%-5.32M
-107.08%-12.37M
-158.70%-5.02M
Net non-operating interest income expense
250.71%1.24M
153.96%259K
46.76%317K
418.02%353K
3,266.67%380K
407.79%237K
-2,723.53%-480K
4,420.00%216K
-628.57%-111K
-33.33%-12K
Total other finance cost
-250.71%-1.24M
-153.96%-259K
-46.76%-317K
-418.02%-353K
-3,266.67%-380K
-407.79%-237K
2,723.53%480K
-4,420.00%-216K
628.57%111K
33.33%12K
Other net income (expense)
Income before tax
14.05%-24.22M
-17.85%-7.94M
-71.08%-8.73M
-125.84%-28.18M
-64.06%-8.26M
-172.24%-8.08M
-143.10%-6.73M
-199.53%-5.1M
-109.68%-12.48M
-158.12%-5.04M
Income tax
0
106.25%34K
21K
-534K
10K
0
-544K
0
0
0
Net income
12.39%-24.22M
-28.76%-7.97M
-71.49%-8.75M
-121.56%-27.65M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.1M
-109.68%-12.48M
-158.12%-5.04M
Net income continuous Operations
12.39%-24.22M
-28.76%-7.97M
-71.49%-8.75M
-121.56%-27.65M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.1M
-109.68%-12.48M
-158.12%-5.04M
Minority interest income
Net income attributable to the parent company
12.39%-24.22M
-28.76%-7.97M
-71.49%-8.75M
-121.56%-27.65M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.1M
-109.68%-12.48M
-158.12%-5.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
12.39%-24.22M
-28.76%-7.97M
-71.49%-8.75M
-121.56%-27.65M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.1M
-109.68%-12.48M
-158.12%-5.04M
Basic earnings per share
14.88%-2.06
-33.33%-0.72
-81.82%-0.8
-101.67%-2.42
-63.64%-0.72
-169.23%-0.7
-107.69%-0.54
-100.00%-0.44
-121.87%-1.2
-148.14%-0.44
Diluted earnings per share
14.88%-2.06
-33.33%-0.72
-81.82%-0.8
-101.67%-2.42
-63.64%-0.72
-169.23%-0.7
-107.69%-0.54
-100.00%-0.44
-121.87%-1.2
-148.14%-0.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
Unqualified Opinion
--
--
--
--
--
--
(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -10.77%25.46M31.04%8.2M70.09%9.05M130.72%28.53M72.01%8.64M187.69%8.32M127.17%6.25M213.13%5.32M107.08%12.37M158.70%5.02M
Selling and administrative expenses -38.75%7.08M-4.94%3.18M-16.04%2.16M91.55%11.56M4.01%2.75M106.13%2.89M130.98%3.34M375.09%2.58M368.40%6.03M283.87%2.64M
-General and administrative expense -38.75%7.08M-4.94%3.18M-16.04%2.16M91.55%11.56M4.01%2.75M106.13%2.89M130.98%3.34M375.09%2.58M368.40%6.03M283.87%2.64M
Research and development costs 8.27%18.38M72.27%5.02M150.89%6.89M168.03%16.98M147.38%5.9M264.69%5.42M122.95%2.91M137.25%2.75M35.23%6.33M90.03%2.38M
Operating profit 10.77%-25.46M-31.04%-8.2M-70.09%-9.05M-130.72%-28.53M-72.01%-8.64M-187.69%-8.32M-127.17%-6.25M-213.13%-5.32M-107.08%-12.37M-158.70%-5.02M
Net non-operating interest income expense 250.71%1.24M153.96%259K46.76%317K418.02%353K3,266.67%380K407.79%237K-2,723.53%-480K4,420.00%216K-628.57%-111K-33.33%-12K
Total other finance cost -250.71%-1.24M-153.96%-259K-46.76%-317K-418.02%-353K-3,266.67%-380K-407.79%-237K2,723.53%480K-4,420.00%-216K628.57%111K33.33%12K
Other net income (expense)
Income before tax 14.05%-24.22M-17.85%-7.94M-71.08%-8.73M-125.84%-28.18M-64.06%-8.26M-172.24%-8.08M-143.10%-6.73M-199.53%-5.1M-109.68%-12.48M-158.12%-5.04M
Income tax 0106.25%34K21K-534K10K0-544K000
Net income 12.39%-24.22M-28.76%-7.97M-71.49%-8.75M-121.56%-27.65M-64.26%-8.27M-172.24%-8.08M-123.47%-6.19M-199.53%-5.1M-109.68%-12.48M-158.12%-5.04M
Net income continuous Operations 12.39%-24.22M-28.76%-7.97M-71.49%-8.75M-121.56%-27.65M-64.26%-8.27M-172.24%-8.08M-123.47%-6.19M-199.53%-5.1M-109.68%-12.48M-158.12%-5.04M
Minority interest income
Net income attributable to the parent company 12.39%-24.22M-28.76%-7.97M-71.49%-8.75M-121.56%-27.65M-64.26%-8.27M-172.24%-8.08M-123.47%-6.19M-199.53%-5.1M-109.68%-12.48M-158.12%-5.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 12.39%-24.22M-28.76%-7.97M-71.49%-8.75M-121.56%-27.65M-64.26%-8.27M-172.24%-8.08M-123.47%-6.19M-199.53%-5.1M-109.68%-12.48M-158.12%-5.04M
Basic earnings per share 14.88%-2.06-33.33%-0.72-81.82%-0.8-101.67%-2.42-63.64%-0.72-169.23%-0.7-107.69%-0.54-100.00%-0.44-121.87%-1.2-148.14%-0.44
Diluted earnings per share 14.88%-2.06-33.33%-0.72-81.82%-0.8-101.67%-2.42-63.64%-0.72-169.23%-0.7-107.69%-0.54-100.00%-0.44-121.87%-1.2-148.14%-0.44
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion----Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg